How it works
A dual GLP-1 and glucagon receptor agonist studied to combine appetite control, glucose signaling, and energy expenditure.
Who it is for
Studied for obesity, overweight, type 2 diabetes, and metabolic fatty-liver disease.
Key benefits
Key benefits include metabolic contexts including weight, glucose, liver fat, and energy markers
